Essais liés2clinical trials
VilleLimogeslocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT04691661

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Radotinib HCl 50 mg Parkinson Phase 2 NCT04691661 Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease ACTIVE_NOT_RECRUITING
blood sample to analyse AMH level on the serum SEP À vérifier NCT07164924 FERTIMUS — Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility COMPLETED